Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Price Down 4.9% – Here’s What Happened

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) shares fell 4.9% during mid-day trading on Tuesday . The company traded as low as $5.03 and last traded at $5.03. 573,880 shares changed hands during trading, a decline of 33% from the average session volume of 858,881 shares. The stock had previously closed at $5.29.

Analyst Ratings Changes

Several research analysts have recently weighed in on SENS shares. Mizuho decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday. Stifel Nicolaus cut their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. HC Wainwright decreased their price objective on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Finally, Weiss Ratings downgraded Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Senseonics Holdings, Inc. Common Stock has an average rating of “Moderate Buy” and an average price target of $17.20.

Senseonics Holdings, Inc. Common Stock Trading Down 0.2%

The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05. The stock has a market cap of $214.87 million, a P/E ratio of -2.57 and a beta of 0.99. The company has a 50-day moving average of $6.11.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%.The business had revenue of $11.71 million during the quarter. Research analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current fiscal year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In related news, Director Douglas A. Roeder bought 22,686 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was bought at an average cost of $5.56 per share, for a total transaction of $126,134.16. Following the completion of the purchase, the director directly owned 144,635 shares in the company, valued at approximately $804,170.60. The trade was a 18.60% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 4.70% of the company’s stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently made changes to their positions in the stock. Ausdal Financial Partners Inc. grew its stake in Senseonics Holdings, Inc. Common Stock by 50.0% during the 3rd quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company’s stock worth $46,000 after buying an additional 35,000 shares during the last quarter. GSK plc bought a new stake in Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at $60,000. Townsend Asset Management Corp NC ADV acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at $60,000. Kestra Advisory Services LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the first quarter valued at $68,000. Finally, Sanctuary Advisors LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter worth about $71,000. Institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.